This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Deciphera Pharmaceuticals, LLC. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: The Innovations of Patrick Kearney
Introduction
Patrick Kearney is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of kinase inhibitors. His work focuses on innovative methods for treating diseases associated with specific kinases.
Latest Patents
Patrick Kearney holds a patent for "GCN2 and PERK kinase inhibitors and methods of use thereof." This patent describes compounds that are inhibitors of GCN2 kinase or PERK kinase. The compounds include various forms such as pharmaceutically acceptable salts, enantiomers, stereoisomers, and tautomers. The methods outlined in the patent aim to treat diseases linked to these kinases.
Career Highlights
Patrick Kearney is currently employed at Deciphera Pharmaceuticals, LLC, where he continues to advance his research and development efforts. His work at Deciphera has positioned him as a key player in the biotechnology sector, contributing to the company's innovative projects.
Collaborations
Some of his notable coworkers include Daniel L Flynn and Jeffery Zwicker. Their collaboration enhances the research environment and fosters innovation within the company.
Conclusion
Patrick Kearney's contributions to the field of biotechnology through his patent and work at Deciphera Pharmaceuticals highlight his role as an influential inventor. His innovative approaches to kinase inhibitors are paving the way for new treatments in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile